Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 10, 2021

SELL
$56.61 - $80.46 $735 - $1,045
-13 Closed
0 $0
Q1 2021

May 06, 2021

SELL
$86.23 - $125.19 $603 - $876
-7 Reduced 35.0%
13 $1,000
Q4 2020

Feb 03, 2021

SELL
$79.17 - $111.47 $79 - $111
-1 Reduced 4.76%
20 $2,000
Q3 2020

Oct 30, 2020

BUY
$81.91 - $134.94 $819 - $1,349
10 Added 90.91%
21 $2,000
Q2 2020

Aug 14, 2020

BUY
$54.33 - $89.52 $597 - $984
11 New
11 $1,000
Q1 2019

May 13, 2019

SELL
$48.23 - $66.16 $1,446 - $1,984
-30 Closed
0 $0
Q3 2018

Nov 13, 2018

SELL
$52.05 - $66.51 $780 - $997
-15 Reduced 33.33%
30 $2,000
Q2 2018

Aug 13, 2018

SELL
$48.33 - $55.64 $724 - $834
-15 Reduced 25.0%
45 $2,000
Q1 2018

May 14, 2018

BUY
$44.44 - $54.39 $2,666 - $3,263
60 New
60 $3,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $438M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Institutional & Family Asset Management, LLC Portfolio

Follow Institutional & Family Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Institutional & Family Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Institutional & Family Asset Management, LLC with notifications on news.